Background:Basal cell carcinoma is the most common type of neoplasia of the periocular region accounting for 90% of palpebral tumors. Its incidence has increased significantly over the past years.Despite its slow progression, which rarely metastasizes, its extension and locationhamper treatment of the periocular region.
There is a numberof available treatments which must take into account the patient´s age and medical history, aesthetic results, anatomical position, tumor size and margins, besides histological patterns, number of lesions and whether it is a primary or recurrent tumor.Surgical treatment is often the chosen protocol for the periocular region. However, new types of therapies have emerged.
Objective: To report the progression of basal cell carcinoma of the eyelids and the benefits of the use of topical Interferon alpha 2b eyedrops as a non-surgical treatment.
Case report: A 21-year-old female patient with a history of Xeroderma Pigmentosum with palpebral lesion to the left in which the anatomopathological examination was consistent with basal cell carcinoma and a 67-year-old female patient with a lesion covering upper right eyelid.Cases were treated with 1 million IU/ml of topical IFN-alpha2b four times a day for three and six months.
Conclusions:The use of IFN-alpha2b for the treatment of basal cell carcinoma offers satisfactory results.It has proven to be promising, rapid, safe,effective with few complications,besides minimizing or rendering a major surgery unnecessary.
- Journal
- Articles
- Author Center
- Society
Editorial Board
The ESMED Editorial Board is comprised of experts from around the world.
Meet the community
See what our members have been working on.
Membership
Join ESMED for access to member-only content, congress discounts, and more.
- Policy